Clinical Trials on SARS-CoV-2 Serological Status in Hong Kong
Total 28 results
-
Chinese University of Hong KongCompletedIntention to Get SARS-CoV-2 Vaccination | Intention to Get SARS-CoV-2 Antibody TestHong Kong
-
Chinese University of Hong KongTerminated
-
Chinese University of Hong KongEnrolling by invitationHIV Infections | SARS-CoV-2 Infection | Vaccination; InfectionChina
-
The University of Hong KongNot yet recruitingObesity | PreDiabetes | Type 2 DiabetesHong Kong
-
Daiichi Sankyo Co., Ltd.CompletedType 2 Diabetes Mellitus | Diabetic Nephropathy | ProteinuriaJapan, China
-
BioNTech SECompletedCOVID-19 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS (Disease)United States, Germany, Turkey, South Africa
-
AstraZenecaActive, not recruitingSARS-CoV-2United States, Belgium, United Kingdom, Brazil, Germany
-
Mahidol UniversityChulalongkorn University; Ministry of Health, Thailand; Yuvabadhana foundation; Zero COVID ThailandCompletedCoronavirus Infections | Covid19 | SARS-CoV-2 | Community TransmissionsThailand
-
AstraZenecaRecruitingCOVID-19 | SARS-CoV-2 InfectionUnited States
-
Gilead SciencesApproved for marketingSARS-CoV2 InfectionUnited States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
-
Invivyd, Inc.Active, not recruiting
-
NovavaxCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States
-
Regeneron PharmaceuticalsTerminated
-
Immunome, Inc.United States Department of DefenseRecruiting
-
ModernaTX, Inc.Active, not recruitingInfluenza | SARS-CoV-2United States
-
PfizerCompleted
-
ShionogiRecruitingSARS-CoV-2 InfectionJapan, United States
-
MedicagoActive, not recruitingSARS-CoV-2 InfectionUnited States, Canada, United Kingdom, Argentina, Brazil, Mexico
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Germany, Turkey, South Africa, Argentina, Brazil
-
Regeneron PharmaceuticalsCompletedHealthy ParticipantsUnited States, Moldova, Republic of, Romania
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Brazil, South Africa, Germany, Canada, Israel
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)Active, not recruitingA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
AstraZenecaActive, not recruitingCOVID-19, SARS-CoV-2United States, Belgium, Canada, France, Spain, Denmark, Thailand, Vietnam, Korea, Republic of, United Kingdom, Malaysia, Israel, Taiwan, Australia, Germany, Poland, Singapore, United Arab Emirates
-
HighTide Biopharma Pty LtdActive, not recruitingType 2 Diabetes | Nonalcoholic Steatohepatitis (NASH)United States, China, Hong Kong
-
AstraZenecaCompletedType 2 Diabetes Mellitus, CKD and AlbuminuriaUnited States, Spain, Canada, Korea, Republic of, Mexico, Japan, Taiwan, Australia, South Africa
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany, Spain, United States, Canada, Taiwan, Korea, Republic of, Finland, Denmark, France, Japan, Philippines, Vietnam
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina